标题
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
作者
关键词
-
出版物
LEUKEMIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-06
DOI
10.1038/s41375-021-01376-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hematological disorder associated Cxcr4-gain-of-function mutation leads to uncontrolled extrafollicular immune response
- (2021) Nagham Alouche et al. BLOOD
- CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma
- (2020) Peter Herhaus et al. JOURNAL OF NUCLEAR MEDICINE
- The BLIMP1—EZH2 nexus in a non-Hodgkin lymphoma
- (2020) Kimberley Jade Anderson et al. ONCOGENE
- Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia
- (2020) Begüm Alankus et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
- (2020) Franck Morschhauser et al. LANCET ONCOLOGY
- Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia.
- (2020) Jenny Klintman et al. BLOOD
- Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
- (2020) Vivien Kohlhaas et al. BLOOD
- RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma
- (2019) Amir Farmanbar et al. npj Genomic Medicine
- A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia
- (2019) Leslie A. Andritsos et al. LEUKEMIA & LYMPHOMA
- CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas
- (2019) Linfeng Chen et al. HAEMATOLOGICA
- Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma
- (2018) Clara Recasens-Zorzo et al. HAEMATOLOGICA
- [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia
- (2018) Marius E. Mayerhoefer et al. INVESTIGATIVE RADIOLOGY
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma
- (2018) Clara Recasens-Zorzo et al. HAEMATOLOGICA
- PLK1: a promising and previously unexplored target in double-hit lymphoma
- (2018) Quais N. Hassan et al. JOURNAL OF CLINICAL INVESTIGATION
- Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization
- (2017) Christelle Freitas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
- (2017) Gero Knittel et al. Nature Communications
- Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis
- (2017) Lijun Li et al. Oncotarget
- Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
- (2016) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization
- (2016) Vincent Biajoux et al. Cell Reports
- Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment
- (2015) S. Scala CLINICAL CANCER RESEARCH
- Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors
- (2015) S. Ganghammer et al. HAEMATOLOGICA
- BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
- (2015) S-S Chen et al. LEUKEMIA
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
- (2015) Jiayu Chen et al. Oncotarget
- Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging
- (2015) Hans Jürgen Wester et al. Theranostics
- VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
- (2015) Mikhail Shugay et al. PLoS Computational Biology
- Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors
- (2015) S. Ganghammer et al. HAEMATOLOGICA
- CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion
- (2014) Shengwen Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival
- (2014) María José Moreno et al. JOURNAL OF PATHOLOGY
- The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom’s Macroglobulinemia
- (2014) Y Cao et al. LEUKEMIA
- SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy
- (2014) Aldo M. Roccaro et al. Cell Reports
- Accelerated progression of chronic lymphocytic leukemia in E -TCL1 mice expressing catalytically inactive RAG1
- (2013) V. K. Nganga et al. BLOOD
- The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
- (2013) Z. R. Hunter et al. BLOOD
- Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
- (2013) R. D. Morin et al. BLOOD
- Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches
- (2013) Lei Ding et al. NATURE
- PI 3-kinase-dependent phosphorylation of Plk1–Ser99 promotes association with 14-3-3γ and is required for metaphase–anaphase transition
- (2013) Kousuke Kasahara et al. Nature Communications
- Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice
- (2012) K. Balabanian et al. BLOOD
- The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
- (2012) S. Sadasivam et al. GENES & DEVELOPMENT
- Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma
- (2012) S. Uddin et al. HAEMATOLOGICA
- CXCR7 impact on CXCL12 biology and disease
- (2012) Lorena Sánchez-Martín et al. TRENDS IN MOLECULAR MEDICINE
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases
- (2011) Haipeng Shao et al. MODERN PATHOLOGY
- A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers
- (2010) Celine Lefebvre et al. Molecular Systems Biology
- Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia
- (2009) D. Crowther-Swanepoel et al. BLOOD
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
- (2008) Zheng Fu et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now